✦ LIBER ✦

Pharmaceutical design II: Nucleic acid binding drugs

✍ Scribed by Larrick, James W.; Wang, Yuqiang

Book ID: 124124172
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 198 KB
Volume: 149
Category: Article
ISSN: 0378-1119
DOI: 10.1016/0378-1119(94)90404-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nucleic acid binding drugs. II. Proflavi

Nucleic acid binding drugs. II. Proflavine free base

✍ Achari, A. ;Neidle, S. 📂 Article 📅 1976 🏛 International Union of Crystallography ⚖ 311 KB

Nucleic acid targeted drug design

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Therapeutic potential of nucleic acid-bi

Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: Binding aspects and implications for drug design

✍ Kakali Bhadra; Gopinatha Suresh Kumar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Abstract Isoquinoline alkaloids represent a group of natural products with remarkable importance in the contemporary biomedical research and drug discovery programs. Several members of this group exhibit immense pharmacological and biological properties, including potential anticancer properties

ChemInform Abstract: Therapeutic Potenti

ChemInform Abstract: Therapeutic Potential of Nucleic Acid-Binding Isoquinoline Alkaloids: Binding Aspects and Implications for Drug Design

✍ Kakali Bhadra; Gopinatha Suresh Kumar 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 11 KB 👁 2 views

## Abstract Review: 201 refs.

A discovery funnel for nucleic acid bind

A discovery funnel for nucleic acid binding drug candidates

✍ Patrick A. Holt; Robert Buscaglia; John O. Trent; Jonathan B. Chaires 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Structure-based drug design: From nuclei

Structure-based drug design: From nucleic acid to membrane protein targets

✍ Magdalena M. Dailey; Chayanendu Hait; Patrick A. Holt; Jon M. Maguire; Jason B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 902 KB